<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39397872</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1658-3612</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of Taibah University Medical Sciences</Title><ISOAbbreviation>J Taibah Univ Med Sci</ISOAbbreviation></Journal><ArticleTitle>Exploring the potential of <i>Scabiosa columbaria</i> in Alzheimer's disease treatment: An <i>in silico</i> approach.</ArticleTitle><Pagination><StartPage>947</StartPage><EndPage>960</EndPage><MedlinePgn>947-960</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtumed.2024.09.003</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Alzheimer's disease (AD) is posing an increasing global threat and currently lacks effective treatments. Therefore, this study was aimed at exploring phytochemicals in <i>Scabiosa columbaria</i> (<i>S. columbaria</i>) as inhibitors of acetylcholinesterase (AChE), β-site APP cleavage enzyme 1 (BACE1), and TNF-α converting enzyme (TACE) in AD. <i>S. columbaria</i> contains various bioactive compounds, such as chlorogenic acid, linalool, and catechins, which are known for their detoxification properties, capacity to resist and manage harmful moisture buildup, and therapeutic roles in COVID-19. Several studies have also shown that <i>S. columbaria</i> extract has strong antioxidant activity, and may potentially decrease neuroinflammation in AD. Therefore, this study investigated the interactions between <i>S. columbaria</i> phytochemicals and key enzymes associated with AD, thus providing opportunities for the development of new therapeutic candidates.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total of 27 phytochemicals were evaluated for their inhibitory activity against AChE, BACE1, and TACE with YASARA Structure. ADMET profiles and toxicity were assessed. The top candidate compounds underwent 100 ns MD simulations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All ligands met Lipinski's rule and showed low toxicity. Catechins, compared with the known drug galantamine, showed higher inhibitory activity and interacted with additional active sites on AChE, thus suggesting potentially higher efficacy. Moreover, chlorogenic acid showed stronger inhibitory activity against TACE than the control drug (aryl-sulfonamide), thereby suggesting a different mechanism of action. MD simulation revealed that the formed complexes had good stability. However, further exploration is necessary.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED"><i>S. columbaria</i> derivative compounds are promising drug candidates because of their properties, including the affinity of chlorogenic acid toward TACE and hydrogen bond enhancing ligand-receptor interactions. MD simulation indicated stable ligand-protein complexes, and the radius of gyration and MM-PBSA calculations revealed favorable binding and interaction energies. Our findings demonstrate the identified compounds' potential for further drug development.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Irsal</LastName><ForeName>Riyan A P</ForeName><Initials>RAP</Initials><AffiliationInfo><Affiliation>Biomatics, Bogor, West Java, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gholam</LastName><ForeName>Gusnia M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bioinformatics Research Center, Indonesian Institute of Bioinformatics, Malang, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dwicesaria</LastName><ForeName>Maheswari A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mansyah</LastName><ForeName>Tiyara F</ForeName><Initials>TF</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Mathematics and Natural Sciences, Bogor Agricultural University, Bogor, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chairunisa</LastName><ForeName>Fernanda</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Universitas Nasional, Department of Biology, South Jakarta, Indonesia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Saudi Arabia</Country><MedlineTA>J Taibah Univ Med Sci</MedlineTA><NlmUniqueID>101621911</NlmUniqueID><ISSNLinking>1658-3612</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="ara"><AbstractText Label="أهداف البحث" NlmCategory="UNASSIGNED">يعد مرض الزهايمر تهديدا عالميا متزايدا، ولا يوجد علاج فعال له حاليا. ولذلك، تهدف هذه الدراسة إلى استكشاف المركبات النباتية في نبات الجرباء العمودية كمثبطات لإنزيم أسيتيل كولين إستيراز، وإنزيم شطر البروتين السلائف للأميلويد بيتا 1، وإنزيم محول عامل نخر الورم ألفا في مرض الزهايمر. يحتوي نبات الجرباء العمودية عادة على مركبات نشطة بيولوجيا مختلفة، مثل حمض الكلوروجينيك، واللينالول، والكاتيكين، المعروفة بخصائصها في إزالة السموم، والقدرة على التغلب على احتباس الرطوبة السامة، والآليات العلاجية في كوفيد-19. وقد أظهرت العديد من الدراسات أيضا أن المستخلص له نشاط مضاد للأكسدة قوي، مما قد يقلل من الالتهاب العصبي في مرض الزهايمر. في هذا السياق، توفر هذه الدراسة الحالية فرصا لتطوير المواد الكيميائية النباتية لنبات الجرباء العمودية كمرشحين علاجيين جدد لمرض الزهايمر من خلال دراسة التفاعلات مع الإنزيمات الرئيسية.</AbstractText><AbstractText Label="طرق البحث" NlmCategory="UNASSIGNED">تم تقييم 27 مركبا نباتيا للنشاط التثبيطي ضد الإنزيمات المستهدفة باستخدام برنامج "ياسارا ستركتشر". تم تقييم الخصائص الدوائية والحركية والأيضية والسمية للمركبات. خضعت المركبات الأعلى تصنيفا لمحاكاة ديناميكية جزيئية لمدة 100 نانوثانية.</AbstractText><AbstractText Label="النتائج" NlmCategory="UNASSIGNED">استوفت جميع المركبات معايير "ليبينسكي" مع انخفاض كبير في السمية. أظهرت الكاتيكينات نشاطا تثبيطيا أكبر وتفاعلات إضافية مع إنزيم أسيتيل كولين إستيراز مقارنة بدواء الجالانتامين. أظهر حمض الكلوروجينيك نشاطا تثبيطيا أقوى ضد إنزيم محول عامل نخر الورم ألفا مقارنة بدواء المراقبة. أظهرت المحاكاة الديناميكية الجزيئية استقرارا جيدا للمعقدات المتكونة، ولكنها تتطلب المزيد من الاستكشاف.</AbstractText><AbstractText Label="الاستنتاجات" NlmCategory="UNASSIGNED">أظهرت المركبات المشتقة من نبات الجرباء العمودية إمكانات واعدة كمرشحات دوائية لمرض الزهايمر، خاصة حمض الكلوروجينيك في تفاعله مع إنزيم محول عامل نخر الورم ألفا. أكدت المحاكاة الديناميكية الجزيئية وحسابات الطاقة استقرار وقوة الروابط بين المركبات والبروتينات المستهدفة، مما يشير إلى إمكانية تطوير هذه المركبات كعلاجات محتملة لمرض الزهايمر.</AbstractText><CopyrightInformation>© 2024 The Authors.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acetylcholinesterase</Keyword><Keyword MajorTopicYN="N">BACE1</Keyword><Keyword MajorTopicYN="N">Natural anti-AD agent</Keyword><Keyword MajorTopicYN="N">TACE</Keyword><Keyword MajorTopicYN="N">YASARA structure</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39397872</ArticleId><ArticleId IdType="pmc">PMC11470288</ArticleId><ArticleId IdType="doi">10.1016/j.jtumed.2024.09.003</ArticleId><ArticleId IdType="pii">S1658-3612(24)00111-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Passeri E., Elkhoury K., Morsink M., Broersen K., Linder M., Tamayol A., et al. Alzheimer's disease: treatment strategies and their limitations. Int J Mol Sci. 2022;23 doi: 10.3390/ijms232213954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232213954</ArticleId><ArticleId IdType="pmc">PMC9697769</ArticleId><ArticleId IdType="pubmed">36430432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannopoulou K.G., Papageorgiou S.G. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12 doi: 10.1177/1179573520907397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1179573520907397</ArticleId><ArticleId IdType="pmc">PMC7050025</ArticleId><ArticleId IdType="pubmed">32165850</ArticleId></ArticleIdList></Reference><Reference><Citation>Turana Y., Tengkawan J., Suswanti I., Suharya D., Riyadina W., Pradono J. Primary prevention of Alzheimer's disease in Indonesia. Int J Aging Res. 2019 doi: 10.28933/ijoar-2019-06-2506.</Citation><ArticleIdList><ArticleId IdType="doi">10.28933/ijoar-2019-06-2506</ArticleId></ArticleIdList></Reference><Reference><Citation>Gnanaraj C., Sekar M., Fuloria S., Swain S.S., Gan S.H., Chidambaram K., et al. In silico molecular docking analysis of karanjin against Alzheimer's and Parkinson's diseases as a potential natural lead molecule for new drug design, development and therapy. Molecules. 2022;27:2834. doi: 10.3390/molecules27092834.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27092834</ArticleId><ArticleId IdType="pmc">PMC9100660</ArticleId><ArticleId IdType="pubmed">35566187</ArticleId></ArticleIdList></Reference><Reference><Citation>Barthold D., Joyce G., Ferido P., Drabo E.F., Marcum Z.A., Gray S.L., et al. Pharmaceutical treatment for Alzheimer's disease and related dementias: utilization and disparities. J Alzheimers Dis. 2020;76:579–589. doi: 10.3233/JAD-200133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200133</ArticleId><ArticleId IdType="pmc">PMC7825250</ArticleId><ArticleId IdType="pubmed">32538845</ArticleId></ArticleIdList></Reference><Reference><Citation>Akar Z. Chemical compositions by using LC–MS/MS and GC–MS and antioxidant activities of methanolic extracts from leaf and flower parts of Scabiosa columbaria subsp. columbaria var. columbaria L. Saudi J Biol Sci. 2021;28:6639–6644. doi: 10.1016/j.sjbs.2021.07.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2021.07.039</ArticleId><ArticleId IdType="pmc">PMC8568819</ArticleId><ArticleId IdType="pubmed">34764779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Pan X., Jiang L., Chu Y., Gao S., Jiang X., et al. The biological activity mechanism of chlorogenic acid and its applications in food industry: a review. Front Nutr. 2022;9 doi: 10.3389/fnut.2022.943911.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.943911</ArticleId><ArticleId IdType="pmc">PMC9278960</ArticleId><ArticleId IdType="pubmed">35845802</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah T., Xia K.-Y., Shah Z., Baloch Z. Therapeutic mechanisms and impact of traditional Chinese medicine on COVID-19 and other influenza diseases. Pharmacol Res Mod Chin Med. 2022;2 doi: 10.1016/j.prmcm.2021.100029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prmcm.2021.100029</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Zhang X., Gu L., Wu N., Zhang L., Lu J., Li Q. Network pharmacology study of heat-clearing and detoxifying traditional Chinese medicine for Alzheimer's disease. Evid Based Complement Alternat Med. 2020;2020:1–10. doi: 10.1155/2020/7831675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/7831675</ArticleId><ArticleId IdType="pmc">PMC7196989</ArticleId><ArticleId IdType="pubmed">32382304</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawar S.H., Upganlawar A.B., Upasani C.D. Treat. Nutraceuticals, Suppl. Herb. Med. Neurol. Disord. Elsevier; 2023. Therapeutic benefits of phenolic acids in peripheral neuropathy; pp. 753–771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-90052-2.00036-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin M., Gong W., Chen Q., Sun L., Wang Y., Fan X. Evaluation of the potential sensitization of chlorogenic acid: a meta-analysis. Evid Based Complement Alternat Med. 2013;2013:1–9. doi: 10.1155/2013/208467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/208467</ArticleId><ArticleId IdType="pmc">PMC3670571</ArticleId><ArticleId IdType="pubmed">23762111</ArticleId></ArticleIdList></Reference><Reference><Citation>He C.-L., Tang Y., Wu J.-M., Long T., Yu L., Teng J.-F., et al. Chlorogenic acid delays the progression of Parkinson's disease via autophagy induction in Caenorhabditis elegans. Nutr Neurosci. 2023;26:11–24. doi: 10.1080/1028415X.2021.2009993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2021.2009993</ArticleId><ArticleId IdType="pubmed">34927571</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Wang F., Li Z., Mu Y., Yong V.W., Xue M. Neuroprotective effects of chlorogenic acid in a mouse model of intracerebral hemorrhage associated with reduced extracellular matrix metalloproteinase inducer. Biomolecules. 2022;12:1020. doi: 10.3390/biom12081020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12081020</ArticleId><ArticleId IdType="pmc">PMC9332591</ArticleId><ArticleId IdType="pubmed">35892330</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermawati E., Arfian N., Mustofa M., Partadiredja G. Chlorogenic acid ameliorates memory loss and hippocampal cell death after transient global ischemia. Eur J Neurosci. 2020;51:651–669. doi: 10.1111/ejn.14556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.14556</ArticleId><ArticleId IdType="pubmed">31437868</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos É.R.Q., Maia J.G.S., Fontes-Júnior E.A., do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: a review. Curr Neuropharmacol. 2022;20:1073–1092. doi: 10.2174/1570159X19666210920094504.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1570159X19666210920094504</ArticleId><ArticleId IdType="pmc">PMC9886818</ArticleId><ArticleId IdType="pubmed">34544345</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzmán-Gutiérrez S.L., Bonilla-Jaime H., Gómez-Cansino R., Reyes-Chilpa R. Linalool and β-pinene exert their antidepressant-like activity through the monoaminergic pathway. Life Sci. 2015;128:24–29. doi: 10.1016/j.lfs.2015.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2015.02.021</ArticleId><ArticleId IdType="pubmed">25771248</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu P., Wang K., Lu C., Dong L., Gao L., Yan M., et al. The protective effect of lavender essential oil and its main component linalool against the cognitive deficits induced by D-galactose and aluminum trichloride in mice. Evid Based Complement Alternat Med. 2017;2017:1–11. doi: 10.1155/2017/7426538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7426538</ArticleId><ArticleId IdType="pmc">PMC5424179</ArticleId><ArticleId IdType="pubmed">28529531</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal O., Dalhat M.H., Altamimi A.S.A., Rasool R., Alzarea S.I., Almalki W.H., et al. Green tea catechins attenuate neurodegenerative diseases and cognitive deficits. Molecules. 2022;27:7604. doi: 10.3390/molecules27217604.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27217604</ArticleId><ArticleId IdType="pmc">PMC9655201</ArticleId><ArticleId IdType="pubmed">36364431</ArticleId></ArticleIdList></Reference><Reference><Citation>Otang-Mbeng W., Sagbo I.J. Anti-melanogenesis, antioxidant and anti-tyrosinase activities of Scabiosa columbaria L. Processes. 2020;8:236. doi: 10.3390/pr8020236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pr8020236</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray B., Maloney B., Sambamurti K., Karnati H.K., Nelson P.T., Greig N.H., et al. Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer's disease. Transl Psychiatry. 2020;10:47. doi: 10.1038/s41398-020-0709-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-020-0709-x</ArticleId><ArticleId IdType="pmc">PMC7026402</ArticleId><ArticleId IdType="pubmed">32066688</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalliolias G.D., Ivashkiv L.B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49–62. doi: 10.1038/nrrheum.2015.169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2015.169</ArticleId><ArticleId IdType="pmc">PMC4809675</ArticleId><ArticleId IdType="pubmed">26656660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung J., Rudolph M.J., Burshteyn F., Cassidy M.S., Gary E.N., Love J., et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem. 2012;55:10282–10286. doi: 10.1021/jm300871x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm300871x</ArticleId><ArticleId IdType="pubmed">23035744</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumming J.N., Smith E.M., Wang L., Misiaszek J., Durkin J., Pan J., et al. Structure based design of iminohydantoin BACE1 inhibitors: identification of an orally available, centrally active BACE1 inhibitor. Bioorg Med Chem Lett. 2012;22:2444–2449. doi: 10.1016/j.bmcl.2012.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2012.02.013</ArticleId><ArticleId IdType="pubmed">22390835</ArticleId></ArticleIdList></Reference><Reference><Citation>Govinda Rao B., Bandarage U.K., Wang T., Come J.H., Perola E., Wei Y., et al. Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides. Bioorg Med Chem Lett. 2007;17:2250–2253. doi: 10.1016/j.bmcl.2007.01.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2007.01.064</ArticleId><ArticleId IdType="pubmed">17289381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar G., Kumar A., Mahajan A. Open source software tools for computer aided drug design. Int J Res Pharm Sci. 2018;9:86. doi: 10.26452/ijrps.v9i1.1191.</Citation><ArticleIdList><ArticleId IdType="doi">10.26452/ijrps.v9i1.1191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lestari E.D.P., Widyarti S., Santjojo D.H., Widodo N., Sumitro S.B. Computational approach to determine the combination of polyherbs based on the interaction of their metal complexes on the mucoadhesive properties of type II mucin. J Appl Pharm Sci. 2023 doi: 10.7324/JAPS.2023.35062.</Citation><ArticleIdList><ArticleId IdType="doi">10.7324/JAPS.2023.35062</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan L., Yang H., Cai Y., Sun L., Di P., Li W., et al. ADMET-score – a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019;10:148–157. doi: 10.1039/C8MD00472B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8MD00472B</ArticleId><ArticleId IdType="pmc">PMC6350845</ArticleId><ArticleId IdType="pubmed">30774861</ArticleId></ArticleIdList></Reference><Reference><Citation>Putera Irsal R.A., Hami Seno D.S., Safithri M., Kurniasih R. Penapisan Virtual Senyawa Aktif Sirih Merah (Piper crocatum) sebagai inhibitor angiotensin converting enzyme. J Farmamedika (Pharmamedica J) 2022;7:104–113. doi: 10.47219/ath.v7i2.157.</Citation><ArticleIdList><ArticleId IdType="doi">10.47219/ath.v7i2.157</ArticleId></ArticleIdList></Reference><Reference><Citation>Irsal R.A.P., Gholam G.M., Dwicesaria M.A., Chairunisa F. Computational investigation of Y. aloifolia variegate as anti-Human Immunodeficiency Virus (HIV) targeting HIV-1 protease: a multiscale in-silico exploration. Pharmacol Res Mod Chin Med. 2024;11 doi: 10.1016/j.prmcm.2024.100451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prmcm.2024.100451</ArticleId></ArticleIdList></Reference><Reference><Citation>Chairunisa F., Safithri M., Andrianto D., Kurniasih R., Irsal R.A.P. Molecular docking of red betel leaf bioactive compounds (Piper crocatum) as lipoxygenase inhibitor. Indones J Pharm Sci Technol. 2023;10:90. doi: 10.24198/ijpst.v10i2.38934.</Citation><ArticleIdList><ArticleId IdType="doi">10.24198/ijpst.v10i2.38934</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha R.K., Khan R.J., Amera G.M., Singh E., Pathak A., Jain M., et al. Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis. J Mol Model. 2020;26:304. doi: 10.1007/s00894-020-04557-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00894-020-04557-4</ArticleId><ArticleId IdType="pubmed">33068184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Jun M. Dual BACE1 and cholinesterase inhibitory effects of phlorotannins from Ecklonia cava—an in vitro and in silico study. Mar Drugs. 2019;17:91. doi: 10.3390/md17020091.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/md17020091</ArticleId><ArticleId IdType="pmc">PMC6410325</ArticleId><ArticleId IdType="pubmed">30717208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z.-R., Huang J.-B., Yang S.-L., Hong F.-F. Role of cholinergic signaling in Alzheimer's disease. Molecules. 2022;27:1816. doi: 10.3390/molecules27061816.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27061816</ArticleId><ArticleId IdType="pmc">PMC8949236</ArticleId><ArticleId IdType="pubmed">35335180</ArticleId></ArticleIdList></Reference><Reference><Citation>Khandhar P., Trang A.  StatPearls; Treasure Island: 2024. Physiology, acetylcholinesterase.https://www.ncbi.nlm.nih.gov/books/NBK539735</Citation><ArticleIdList><ArticleId IdType="pubmed">30969557</ArticleId></ArticleIdList></Reference><Reference><Citation>dos S. Moreira N.C., de F. Lima J.E.B., Marchiori M.F., Carvalho I., Sakamoto-Hojo E.T. Neuroprotective effects of cholinesterase inhibitors: current scenario in therapies for Alzheimer's disease and future perspectives. J Alzheimers Dis Rep. 2022;6:177–193. doi: 10.3233/ADR-210061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/ADR-210061</ArticleId><ArticleId IdType="pmc">PMC9108627</ArticleId><ArticleId IdType="pubmed">35591949</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito D.M.S., Lima O.G., Mesquita F.P., da Silva E.L., de Moraes M.E.A., Burbano R.M.R., et al. A shortcut from genome to drug: the employment of bioinformatic tools to find new targets for gastric cancer treatment. Pharmaceutics. 2023;15:2303. doi: 10.3390/pharmaceutics15092303.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics15092303</ArticleId><ArticleId IdType="pmc">PMC10535099</ArticleId><ArticleId IdType="pubmed">37765273</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathod S., Shinde K., Porlekar J., Choudhari P., Dhavale R., Mahuli D., et al. Computational exploration of anti-cancer potential of flavonoids against cyclin-dependent kinase 8: an in silico molecular docking and dynamic approach. ACS Omega. 2023;8:391–409. doi: 10.1021/acsomega.2c04837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.2c04837</ArticleId><ArticleId IdType="pmc">PMC9835631</ArticleId><ArticleId IdType="pubmed">36643495</ArticleId></ArticleIdList></Reference><Reference><Citation>Şahin İ., Çeşme M., Güngör Ö., Özgeriş F.B., Köse M., Tümer F. New sulfonamide derivatives based on 1,2,3-triazoles: synthesis, in vitro biological activities and in silico studies. J Biomol Struct Dyn. 2024;42:4782–4799. doi: 10.1080/07391102.2023.2222833.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2023.2222833</ArticleId><ArticleId IdType="pubmed">37317998</ArticleId></ArticleIdList></Reference><Reference><Citation>Musial C., Kuban-Jankowska A., Gorska-Ponikowska M. Beneficial properties of green tea catechins. Int J Mol Sci. 2020;21:1744. doi: 10.3390/ijms21051744.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051744</ArticleId><ArticleId IdType="pmc">PMC7084675</ArticleId><ArticleId IdType="pubmed">32143309</ArticleId></ArticleIdList></Reference><Reference><Citation>Tajik N., Tajik M., Mack I., Enck P. The potential effects of chlorogenic acid, the main phenolic components in coffee, on health: a comprehensive review of the literature. Eur J Nutr. 2017;56:2215–2244. doi: 10.1007/s00394-017-1379-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-017-1379-1</ArticleId><ArticleId IdType="pubmed">28391515</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh Y., Nakashima Y., Tsukamoto S., Kurohara T., Suzuki M., Sakae Y., et al. N+-C-H···O Hydrogen bonds in protein-ligand complexes. Sci Rep. 2019;9:767. doi: 10.1038/s41598-018-36987-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36987-9</ArticleId><ArticleId IdType="pmc">PMC6347603</ArticleId><ArticleId IdType="pubmed">30683882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira de Freitas R., Schapira M. A systematic analysis of atomic protein–ligand interactions in the PDB. Medchemcomm. 2017;8:1970–1981. doi: 10.1039/C7MD00381A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C7MD00381A</ArticleId><ArticleId IdType="pmc">PMC5708362</ArticleId><ArticleId IdType="pubmed">29308120</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques J.G.O., Costa A.L., Pereira C. Gibbs free energy (ΔG) analysis for the Na–O–H (sodium-oxygen-hydrogen) thermochemical water splitting cycle. Int J Hydrogen Energy. 2019;44:14536–14549. doi: 10.1016/j.ijhydene.2019.04.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijhydene.2019.04.064</ArticleId></ArticleIdList></Reference><Reference><Citation>Case V.B.D.A., Berryman J.T., Betz R.M., Cai Q., Cerutti D.S., Cheatham T.E., III, et al.  The Amber Molecular Dynamics Package. Amber. 2014;14 http://ambermd.org/doc12/Amber14.pdf%0Ahttp://ambermd.org/</Citation></Reference><Reference><Citation>Ghahremanian S., Rashidi M.M., Raeisi K., Toghraie D. Molecular dynamics simulation approach for discovering potential inhibitors against SARS-CoV-2: a structural review. J Mol Liq. 2022;354 doi: 10.1016/j.molliq.2022.118901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molliq.2022.118901</ArticleId><ArticleId IdType="pmc">PMC8916543</ArticleId><ArticleId IdType="pubmed">35309259</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitra S., Dash R. Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors. J Mol Graph Model. 2018;83:42–52. doi: 10.1016/j.jmgm.2018.04.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmgm.2018.04.014</ArticleId><ArticleId IdType="pubmed">29758466</ArticleId></ArticleIdList></Reference><Reference><Citation>Vauquelin G., Charlton S.J. Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action. Br J Pharmacol. 2010;161:488–508. doi: 10.1111/j.1476-5381.2010.00936.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2010.00936.x</ArticleId><ArticleId IdType="pmc">PMC2990149</ArticleId><ArticleId IdType="pubmed">20880390</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon C.H., Wang Y., Fung M.-L., Zhang C., Lim L.W. Rodent models of amyloid-beta feature of Alzheimer's disease: development and potential treatment implications. Aging Dis. 2020;11:1235. doi: 10.14336/AD.2019.1026.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2019.1026</ArticleId><ArticleId IdType="pmc">PMC7505263</ArticleId><ArticleId IdType="pubmed">33014535</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>